Jci_page_head_homepage_01 Jci_page_head_homepage_02
Tanya Ponomaryov, Amnon Peled, Isabelle Petit, Russell S. Taichman, Liliana Habler, Judith Sandbank, Fernando Arenzana-Seisdedos, Aude Magerus, Antonio Caruz, Nobutaka Fujii, Arnon Nagler, Meir Lahav, Martin Szyper-Kravitz, Dov Zipori, Tsvee Lapidot
Published in Volume 106, Issue 11
J Clin Invest. 2000; 106(11):1331–1339 doi:10.1172/JCI10329
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4

Increased levels of SDF-1 in the spleen of NOD/SCID after TBI. (a) SDF-1 mRNA in the BM and spleen from the same mouse per time point. (b) Semisolid colony assay for migrating progenitors to spleen CM collected before, 24 hours, or 48 hours after TBI with and without anti-CXCR4 Ab pretreatment.